ContraFect to Present New Data at the 27th European Congress of Clinical Microbiology and Infectious Disease (ECCMID) YONKERS, NY--(Marketwired - April 19, 2017) - ContraFect Corporation (NASDAQ: CFRX), a biotechnology company focused on the discovery and development of protein and antibody therapeutics for...